We are analyzing https://link.springer.com/article/10.1007/s12016-010-8243-x.

Title:
Hydroxychloroquine: From Malaria to Autoimmunity | Clinical Reviews in Allergy & Immunology
Description:
Quinine was first recognized as a potent antimalarial agent hundreds of years ago. Since then, the beneficial effects of quinine and its more advanced synthetic forms, chloroquine and hydroxychloroquine, have been increasingly recognized in a myriad of other diseases in addition to malaria. In recent years, antimalarials were shown to have various immunomodulatory effects, and currently have an established role in the management of rheumatic diseases, such as systemic lupus erythematosus and rheumatoid arthritis, skin diseases, and in the treatment of chronic Q fever. Lately, additional metabolic, cardiovascular, antithrombotic, and antineoplastic effects of antimalarials were shown. In this review, we discuss the known various immunomodulatory mechanisms of antimalarials and the current evidence for their beneficial effects in various diseases and in potential novel applications.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Health & Fitness
Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We're unsure how the site profits.

Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Link.springer.com might be earning cash quietly, but we haven't detected the monetization method.

Keywords {🔍}

google, scholar, pubmed, article, cas, hydroxychloroquine, chloroquine, lupus, erythematosus, patients, systemic, diseases, arthritis, med, effect, treatment, clin, cell, effects, cells, cancer, antimalarial, disease, rheum, rheumatol, drug, res, dermatol, inhibition, oral, therapy, diabetes, center, rheumatoid, antiphospholipid, growth, dis, trial, ann, human, drugs, blood, privacy, cookies, content, clinical, malaria, antimalarials, rheumatic, access,

Topics {✒️}

anti-ssa/ro-ssb/la antibody chronic graft-versus-host disease acute graft-versus-host disease gov/malaria/resources/pdf/treatmenttable73109 article ben-zvi month download article/chapter graft-versus-host disease low-dose oral chloroquine low–moderate iron overload antiphospholipid antibody-beta2-glycoprotein insulin-dependent diabetes mellitus induces cell death glucose-6-phosphate dehydrogenase deficiency prospective long-term study article clinical reviews full article pdf smith gd open-label study anti-ssa/ro privacy choices/manage cookies randomized double-blind trial systemic lupus erythematosus colon cancer cells breast cancer cells lesnoni la parola sars coronavirus infection unrelated donor transplantation gov [online] [database mini-review article 08 long-term study cell cycle arrest tumor cell killing hydroxychloroquine-induced myopathy malaria suppression program discoid lupus erythematosus lupus panniculitis treated looney rj jr cell growth inhibition vivo chloroquine-induced inhibition clin res ed safe cancer therapies cross-sectional study arthritis care res severe insulin resistance connective tissue diseases low viral load kikuchi–fujimoto disease european economic area advanced synthetic forms fluorescence probe measurement

Questions {❓}

A new job for an old drug?
Anti-malarials: Are There Benefits Beyond Mild Disease?
Savarino A, Boelaert JR, Cassone A, Majori G, Cauda R (2003) Effects of chloroquine on viral infections: an old drug against today’s diseases?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Hydroxychloroquine: From Malaria to Autoimmunity
         description:Quinine was first recognized as a potent antimalarial agent hundreds of years ago. Since then, the beneficial effects of quinine and its more advanced synthetic forms, chloroquine and hydroxychloroquine, have been increasingly recognized in a myriad of other diseases in addition to malaria. In recent years, antimalarials were shown to have various immunomodulatory effects, and currently have an established role in the management of rheumatic diseases, such as systemic lupus erythematosus and rheumatoid arthritis, skin diseases, and in the treatment of chronic Q fever. Lately, additional metabolic, cardiovascular, antithrombotic, and antineoplastic effects of antimalarials were shown. In this review, we discuss the known various immunomodulatory mechanisms of antimalarials and the current evidence for their beneficial effects in various diseases and in potential novel applications.
         datePublished:2011-01-08T00:00:00Z
         dateModified:2011-01-08T00:00:00Z
         pageStart:145
         pageEnd:153
         sameAs:https://doi.org/10.1007/s12016-010-8243-x
         keywords:
            Chloroquine
            Hydroxychloroquine
            Antimalarial
            Novel
            Therapy
            Lupus
            Allergology
            Immunology
            Internal Medicine
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12016-010-8243-x/MediaObjects/12016_2010_8243_Fig1_HTML.gif
         isPartOf:
            name:Clinical Reviews in Allergy & Immunology
            issn:
               1559-0267
               1080-0549
            volumeNumber:42
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Humana Press Inc
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Ilan Ben-Zvi
               affiliation:
                     name:Sheba Medical Center
                     address:
                        name:Rheumatology Unit, Zabludowicz Center for Autoimmune Diseases and Department of Internal Medicine F, Sheba Medical Center, Tel-Hashomer, Israel
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Shaye Kivity
               affiliation:
                     name:Sheba Medical Center
                     address:
                        name:Rheumatology Unit, Zabludowicz Center for Autoimmune Diseases and Department of Internal Medicine A and C, Sheba Medical Center, Tel-Hashomer, Israel
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Pnina Langevitz
               affiliation:
                     name:Sheba Medical Center
                     address:
                        name:Rheumatology Unit, Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yehuda Shoenfeld
               affiliation:
                     name:Sheba Medical Center
                     address:
                        name:Zabludowicz Center for Autoimmune Diseases and Department of Internal Medicine B, Sheba Medical Center, Tel-Hashomer, Israel
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Hydroxychloroquine: From Malaria to Autoimmunity
      description:Quinine was first recognized as a potent antimalarial agent hundreds of years ago. Since then, the beneficial effects of quinine and its more advanced synthetic forms, chloroquine and hydroxychloroquine, have been increasingly recognized in a myriad of other diseases in addition to malaria. In recent years, antimalarials were shown to have various immunomodulatory effects, and currently have an established role in the management of rheumatic diseases, such as systemic lupus erythematosus and rheumatoid arthritis, skin diseases, and in the treatment of chronic Q fever. Lately, additional metabolic, cardiovascular, antithrombotic, and antineoplastic effects of antimalarials were shown. In this review, we discuss the known various immunomodulatory mechanisms of antimalarials and the current evidence for their beneficial effects in various diseases and in potential novel applications.
      datePublished:2011-01-08T00:00:00Z
      dateModified:2011-01-08T00:00:00Z
      pageStart:145
      pageEnd:153
      sameAs:https://doi.org/10.1007/s12016-010-8243-x
      keywords:
         Chloroquine
         Hydroxychloroquine
         Antimalarial
         Novel
         Therapy
         Lupus
         Allergology
         Immunology
         Internal Medicine
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12016-010-8243-x/MediaObjects/12016_2010_8243_Fig1_HTML.gif
      isPartOf:
         name:Clinical Reviews in Allergy & Immunology
         issn:
            1559-0267
            1080-0549
         volumeNumber:42
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Humana Press Inc
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Ilan Ben-Zvi
            affiliation:
                  name:Sheba Medical Center
                  address:
                     name:Rheumatology Unit, Zabludowicz Center for Autoimmune Diseases and Department of Internal Medicine F, Sheba Medical Center, Tel-Hashomer, Israel
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Shaye Kivity
            affiliation:
                  name:Sheba Medical Center
                  address:
                     name:Rheumatology Unit, Zabludowicz Center for Autoimmune Diseases and Department of Internal Medicine A and C, Sheba Medical Center, Tel-Hashomer, Israel
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Pnina Langevitz
            affiliation:
                  name:Sheba Medical Center
                  address:
                     name:Rheumatology Unit, Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yehuda Shoenfeld
            affiliation:
                  name:Sheba Medical Center
                  address:
                     name:Zabludowicz Center for Autoimmune Diseases and Department of Internal Medicine B, Sheba Medical Center, Tel-Hashomer, Israel
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Clinical Reviews in Allergy & Immunology
      issn:
         1559-0267
         1080-0549
      volumeNumber:42
Organization:
      name:Humana Press Inc
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Sheba Medical Center
      address:
         name:Rheumatology Unit, Zabludowicz Center for Autoimmune Diseases and Department of Internal Medicine F, Sheba Medical Center, Tel-Hashomer, Israel
         type:PostalAddress
      name:Sheba Medical Center
      address:
         name:Rheumatology Unit, Zabludowicz Center for Autoimmune Diseases and Department of Internal Medicine A and C, Sheba Medical Center, Tel-Hashomer, Israel
         type:PostalAddress
      name:Sheba Medical Center
      address:
         name:Rheumatology Unit, Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel
         type:PostalAddress
      name:Sheba Medical Center
      address:
         name:Zabludowicz Center for Autoimmune Diseases and Department of Internal Medicine B, Sheba Medical Center, Tel-Hashomer, Israel
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Ilan Ben-Zvi
      affiliation:
            name:Sheba Medical Center
            address:
               name:Rheumatology Unit, Zabludowicz Center for Autoimmune Diseases and Department of Internal Medicine F, Sheba Medical Center, Tel-Hashomer, Israel
               type:PostalAddress
            type:Organization
      name:Shaye Kivity
      affiliation:
            name:Sheba Medical Center
            address:
               name:Rheumatology Unit, Zabludowicz Center for Autoimmune Diseases and Department of Internal Medicine A and C, Sheba Medical Center, Tel-Hashomer, Israel
               type:PostalAddress
            type:Organization
      name:Pnina Langevitz
      affiliation:
            name:Sheba Medical Center
            address:
               name:Rheumatology Unit, Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel
               type:PostalAddress
            type:Organization
      name:Yehuda Shoenfeld
      affiliation:
            name:Sheba Medical Center
            address:
               name:Zabludowicz Center for Autoimmune Diseases and Department of Internal Medicine B, Sheba Medical Center, Tel-Hashomer, Israel
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Rheumatology Unit, Zabludowicz Center for Autoimmune Diseases and Department of Internal Medicine F, Sheba Medical Center, Tel-Hashomer, Israel
      name:Rheumatology Unit, Zabludowicz Center for Autoimmune Diseases and Department of Internal Medicine A and C, Sheba Medical Center, Tel-Hashomer, Israel
      name:Rheumatology Unit, Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel
      name:Zabludowicz Center for Autoimmune Diseases and Department of Internal Medicine B, Sheba Medical Center, Tel-Hashomer, Israel
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(327)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.33s.

LINK . SPRINGER . COM {}